Cluster headache without autonomic symptoms?
Vigl
M
M
Department of Neurology, University of Vienna Medical School, Vienna, Austria. marion.vigl@univie.ac.at
Zebenholzer
K
K
Wessely
P
P
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D003027:Cluster Headache / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D003937:Diagnosis, Differential; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000031:analogs & derivatives; D000077402:Pantoprazole; D011239:Prednisolone / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013454:Sulfoxides / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D014363:Tryptamines
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D005938:Glucocorticoids; D017366:Serotonin Receptor Agonists; D013454:Sulfoxides; D014230:Triazoles; D014363:Tryptamines; C093622:rizatriptan; D011239:Prednisolone; D000077402:Pantoprazole; D009853:Omeprazole